Navigation Links
AAAS hosts June 20 conference on personalized medicine
Date:6/12/2008

Better knowledge of the body's genetic and molecular machinery is pointing toward new drugs and treatments that are custom-designed for each individual. But this emerging era of personalized medicine, in which doctors aim to prescribe the right medicine in the right amount for the right patient, also brings concerns about genetic privacy, adequacy of insurance coverage and industry marketing strategies.

The American Association for the Advancement of Science and the Food and Drug Law Institute are sponsoring a two-part national conference on personalized medicine on June 20 at the AAAS Headquarters in Washington, D.C. from 9:00 a.m. to 5:00 p.m.

A morning roundtable session will explore personalized medicine through a hypothetical case study about a new biomarker for breast cancer recurrence. The panelists include scientists, government officials and a patient advocate.

The afternoon session on "Implementing Personalized Medicine" will feature a keynote speech by Dr. Mark B. McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution and former head of the Food and Drug Administration. The participants include industry and FDA officials who must grapple with new regulatory and policy issues arising from advances in personalized medicine.

The morning roundtable will be moderated by Susan Dentzer, editor in chief of the journal Health Affairs.

The panelists are:

  • Finley Austin, head, U.S. External Research & Innovation Environment, Hoffmann-La Roche, Inc.
  • Carol Isaacson Barash, principal, Genetics, Ethics & Policy Consulting, Inc.
  • Greg Downing, program director for personalized health care, Office of the Secretary, Department of Health and Human Services
  • Carolina Hinestrosa, executive vice president of programs and planning, National Breast Cancer Coalition
  • Dr. Howard P. Levy, assistant professor, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University
  • Dr. Kavita Patel, deputy staff director, Senate Health, Education, Labor and Pensions Committee
  • Charles Rotimi, director, National Institutes of Health Intramural Center for Genomics and Health Disparities
  • Grail Sipes, partner, Covington & Burling

The afternoon session will be moderated by Jeffrey N. Gibbs, principal, Hyman, Phelps & McNamara, P.C. and Gail H. Javitt, law & policy director for The Genetics and Public Policy Center, The Johns Hopkins University.

The speakers are:

  • Kevin T. Conroy, president and chief executive officer, Third Wave Technologies, Inc.
  • Maryellen de Mars, director for clinical biomarkers, Critical Path Institute
  • Steven I. Gutman, director, Office of In Vitro Diagnostic Device Evaluation & Safety, FDA Center for Devices and Radiological Health
  • Shiew-Mei Huang, deputy director for science, Office of Clinical Pharmacology, FDA Center for Drug Evaluation and Research
  • David J. Hunter, professor of epidemiology and nutrition, Harvard School of Public Health
  • Steve McPhail, president and chief executive officer, Expression Analysis, Inc.
  • Bruce Quinn, senior health policy specialist, Foley Hoag LLP
  • Dr. Allen D. Roses, director, Deane Drug Discovery Institute, Duke University Medical Center; and senior scholar at the Fuqua School of Business

In addition to AAAS and FDLI, the following groups are participating in the conference:

American Society of Human Genetics
Association for Molecular Pathology
Genetic Alliance
The Hastings Center
International Pharmaceutical Privacy Consortium
The Kennedy Institute of Ethics at Georgetown University
Personalized Medicine Coalition


'/>"/>

Contact: Earl Lane
elane@aaas.org
202-326-6431
American Association for the Advancement of Science
Source:Eurekalert

Related medicine news :

1. Voices Against Brain Cancer Hosts Event to Benefit Brain Cancer Research
2. Cystic Fibrosis Foundation Hosts Quality Improvement Summit - Caregivers from 15 States and Canada Gather in Hartford for Intensive Learning
3. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
4. SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
5. TriWest Hosts Military Heroes at National Memorial Day Parade
6. American Red Cross Hosts Heritage of Service Dinner
7. ABQAURP Hosts Third Annual Medical Management Conference in Orlando
8. KN Tranquility Suite(TM) Hosts Spa Indulgences and High-Tea Service on the Magnificent Mile
9. GACLA, Department of Health Hosts PA Latino Health Care Forum
10. Mission Community Hospital Hosts Spring Fundraiser to Refurbish Treasured Valley Emergency Room
11. Denzel Washingtons hometown hosts awarding of scholarships bearing Washington family name
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... of a growing number of cancers and is touted to be the next revolution ... treatment, thus far, has been in the form of immune checkpoint inhibitors such as ...
(Date:3/29/2017)... ... , ... AvePoint , the Microsoft Cloud expert, is pleased to announce ... at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with a ribbon-cutting ... and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint employs more ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... NetworkNewsWire Editorial Coverage  ... There are a number of advantages ... economic arguments also favor its legalization. The benefits include increased ... to legalize and regulate marijuana requires an ecosystem of support ... SING Profile ), American Cannabis Company (OTC: AMMJ), Kush Bottles, ...
(Date:3/29/2017)... AVIV, Israel , March 29, 2017 ... agreement in which Exeltis will obtain exclusive marketing rights for Neurim,s ... ... an age-appropriate drug targeted to treat sleep disorders in children with ... be the first sleep medication approved for children. The ...
Breaking Medicine Technology: